Full Breakdown
Robert F. Kennedy Jr. Initiates Federal Vaccine-Safety Inquiry Amid Political and Scientific Controversy
5/12/2026, 12:01:09 AM
Initiative Overview
Health Secretary Robert F. Kennedy Jr. has directed the Department of Health and Human Services to launch a multi-agency review of vaccine safety. The effort, led by Martin Kulldorff, the department’s chief science and data officer, tasks FDA and CDC scientists, external statistical contractors, and data partners such as Kaiser Permanent to re-examine links between vaccines and chronic conditions—including asthma, allergies, neurological disorders, autism, and the preservative thimerosal. Researchers will compare health outcomes of vaccinated versus unvaccinated children using millions of electronic medical records accessed through the CDC’s Vaccine Safety Datalink. The CDC alone estimates the project will cost $40 million–$50 million.
Historical Context and Prior Efforts
Kennedy’s anti-vaccine stance dates to his 2024 presidential campaign and his co-authored book “Vax-Unvax: Let the Science Speak.” In 2023 he deployed researcher David Geier to probe vaccine data, prompting resignations at the CDC and the ouster of director Susan Monarez. Earlier attempts to alter federal vaccine recommendations, including rescinding guidance on thimerosal-containing flu shots, set a precedent for the current inquiry.
Principal Actors
- Robert F. Kennedy Jr. – Health Secretary, sponsor of the inquiry.
- Martin Kulldorff – Chief science and data officer, veteran vaccine-safety biostatistician.
- Stefanie Spear – Senior adviser overseeing the project.
- Dr. Sara Brenner – Senior counselor for public health, former FDA official.
- Dr. Daniel Jernigan – Former CDC vaccine-safety director, now critic.
- Kayla Hancock – Director, Protect Our Care public-health project, vocal opponent.
- Daniel Salmon – Johns Hopkins vaccine researcher commenting on Kulldorff’s reputation.
- Kaiser Permanent, FDA, CDC, and private data-analysis contractors.
Scope, Funding, and Methodology
The inquiry will: (1) assess overall effects of the childhood vaccine schedule; (2) evaluate potential associations with autism and Guillain-Barré syndrome—where a “slightly elevated rate” was reported; (3) revisit thimerosal safety despite prior consensus of no link to autism; and (4) generate comparative health-outcome data for vaccinated versus unvaccinated cohorts. Statistical expertise from contractors will complement agency analyses of the extensive medical-record database.
Official Government Position
White House officials have asked Kennedy to limit public commentary on vaccines to avoid influencing the November midterm elections. The Health Department describes the review as a “top priority” aimed at addressing the secretary’s long-held hypothesis that vaccines may contribute to chronic disease. The World Health Organization estimates vaccines have saved 154 million lives over the past fifty years.
Scientific and Public-Health Criticism
Kayla Hancock characterizes the project as a “fishing expedition” intended to fuel lawsuits and generate fear. Dr. Jernigan warns that Kennedy will “continue to try and look at the data…to support the conclusions he’s already made.” Researchers note that vaccinated children receive more medical care, creating potential bias in comparative studies. Critics fear the allocation of $40-$50 million to a question already addressed by extensive peer-reviewed research could divert resources from other public-health priorities.
Conflicting Findings and Gaps
While the team identified a modest rise in Guillain-Barré syndrome, broader vaccine safety remains affirmed by existing studies. Thimerosal’s safety is widely accepted, yet Kennedy persists in questioning it and has rescinded related flu-vaccine recommendations. The inquiry’s methodology, interim results, and total budget beyond CDC estimates remain undisclosed, and all source contacts requested anonymity.
Verbatim Quotes
- “It just demonstrates that no matter what the general tone is about vaccines, whether we talk about them or not, the secretary is going to continue to try and look at the data and analyze it in a way that will help support the conclusions that he’s already made,” — Dr. Daniel Jernigan, former CDC vaccine-safety director
- “That’s how you really change policy,” — Robert F. Kennedy Jr., podcast, 2024
- “I’m going to provide that enough science, sufficient science, on each one of these exposures and each one of these injuries, to show who’s causing what and hold them responsible in court.” — Robert F. Kennedy Jr., 2024 podcast
- “Martin had been known for decades as a top-notch vaccine safety scientist,” — Daniel Salmon, Johns Hopkins University researcher
Anticipated Next Steps
The department plans to release interim findings on Guillain-Barré and thimerosal later this year, followed by comprehensive reports on the childhood schedule study. Results could inform future litigation, potential regulatory revisions, and congressional oversight hearings on the allocation of federal research funds.
